The drug is indicated for the treatment of the perennial allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes, running nose.
The product will be marketed under store brand labels and is comparable to the brand Zyrtec.
Marksans Pharma is an Indian pharmaceutical company having a global footprint. The companys strengths lie in research, manufacturing and marketing of finished dosage pharmaceutical formulations.
On a consolidated basis, the company reported an 8.8% fall in net profit to Rs 46.29 crore on a 1.3% rise in net sales to Rs 361 crore in Q2 FY22 over Q2 FY21.
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
